For the analysis, PwC analysts defined merger and acquisition activity as mergers, acquisitions, shareholder spinoffs, capital infusions, consolidations and restructurings involving U.S.-based companies acquired by U.S. or foreign entities.
Here are four additional findings from the report.
1. Healthcare deal values totaled $17.4 billion in the third quarter of this year, down 16 percent from the same period last year.
2. Healthcare deal volumes totaled 211 in the third quarter of 2017, marking an 11 percent decrease from the third quarter of 2016.
3. The third quarter saw six megadeals exceeding $1 billion, for a total of $11.4 billion. This is a significant decrease from the second quarter of this year, although PwC analysts note that was an exceptional quarter.
4. The only subsectors witnessing deal volume growth on a quarterly and yearly basis were behavioral care and managed care. Physician medical group deals grew the most among subsectors in terms of value.
More articles on transactions and valuations:
Report: Hospital M&A slows in Q3; few larger mergers expected for Q4
Dignity Health, Select Medical sign definitive agreement to combine select operations
9 recent hospital transactions and partnerships
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
